The Group's principal activity is to develop, manufacture and market medication delivery systems, critical care devices and specialty injectable pharmaceuticals. The medication delivery systems consist of electronic drug delivery pumps, administration sets and accessories and infusion therapy products to deliver intravenous fluids and medications to patients. The critical care devices are used to monitor cardiac functions in critically ill patients. The specialty injectable pharmaceuticals include generic injectable pharmaceutical products and proprietary injectable pharmaceuticals used in a specific patient population or therapeutic area. It also provides contract manufacturing services to pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. The products offered by the Group are used by hospitals, alternate site clinics, home healthcare providers and long-term care facilities.
Alacra Alerts:
Receive alerts on the latest reports on Hospira, Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
